Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Asian Markets

Berkshire Hathaway Severs Ties with BYD After 17-Year Investment

Andreas Sommer by Andreas Sommer
September 23, 2025
in Asian Markets, Automotive & E-Mobility, Mergers & Acquisitions
0
BYD Stock
0
SHARES
142
VIEWS
Share on FacebookShare on Twitter

Warren Buffett’s Berkshire Hathaway has liquidated its entire stake in Chinese electric vehicle manufacturer BYD, concluding an investment relationship that spanned nearly two decades. The transaction was disclosed in a regulatory filing from Berkshire Hathaway Energy, which reported the value of its BYD investment as zero as of the end of March 2025.

This definitive exit immediately impacted BYD’s share price. The stock declined by over 3% on the Hong Kong exchange, while its US-traded American Depositary Receipts (ADRs) experienced a sharper drop of approximately 4.17%.

Investor Sentiment Shifts as Major Backer Departs

The complete divestment by Berkshire signifies a substantial shift in the investment landscape for BYD. As recently as the end of 2024, the conglomerate’s energy subsidiary reported holding the investment with a value of $415 million. The latest filing confirms the total unwinding of this position, removing a long-standing vote of confidence from one of the world’s most renowned investors.

Beyond the Berkshire exit, BYD faces mounting financial pressures. The company recently revised its 2025 delivery target downward to 4.6 million vehicles, a significant reduction from its previously stated ambitious goal of 5.5 million units.

Delivery figures for July revealed the first monthly decline of the year, with 341,030 vehicles delivered compared to 377,628 in June. Year-over-year growth has nearly flattened, indicating potential saturation trends within the highly competitive Chinese EV market.

Should investors sell immediately? Or is it worth buying BYD?

BYD Maintains Market Leadership Amid Challenges

Despite these headwinds, BYD continues to hold a leading position in China’s electric vehicle sector. The company’s financial performance remains strong, with first-half 2025 revenue reaching 371.3 billion yuan. This represents a 23% increase compared to the same period the previous year and surpasses Tesla’s results for the same timeframe.

Global sales figures also demonstrate resilience. BYD sold 2,145,954 units worldwide in the first six months of the year, marking a 33% growth rate year-over-year. Its international expansion efforts are particularly noteworthy, with overseas sales surging 128% to 464,266 units.

Intensifying Competition Squeezes Profitability

The company is navigating an increasingly fierce price war in its domestic market. In May, BYD slashed prices on several entry-level models by roughly 30%, triggering industry-wide discount battles that are pressuring profit margins across the entire sector.

While Berkshire Hathaway’s departure does not directly affect BYD’s operational capabilities, it eliminates a key institutional anchor that had previously signaled stability and credibility to international investors. The market is now watching to see if the company can maintain its global appeal without the endorsement of Buffett’s long-standing investment.

Ad

BYD Stock: Buy or Sell?! New BYD Analysis from February 7 delivers the answer:

The latest BYD figures speak for themselves: Urgent action needed for BYD investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

BYD: Buy or sell? Read more here...

Tags: BYD
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Potbelly Stock
Analysis

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026
Hbt Financial Stock
Analysis

HBT Financial Stock Surges as Strategic Acquisition Nears Completion

February 7, 2026
Next Post
Metaplanet Stock

Metaplanet Emerges as Major Corporate Bitcoin Holder with Massive Purchase

Bayer Stock

Could Parkinson's Gene Therapy Mark a Turning Point for Bayer?

Siemens Energy Stock

Siemens Energy Faces Crucial Investor Test Amid Stunning Recovery

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com